The Takayasu arteritis (TA) is a rare inflammatory large vessel arteritis which often occurs women in Aisa, one of which is China. The rare cases restricted the development of intervention strategy, especially in female patients who plan to be pregnant. So investigators try to recruit as many TA participants as possible to build a TA cohort so that investigators could manage patients much more professionally and standardized and explore the better interventional strategy for a better outcome as well, with full use of blood and vascular tissues.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The change of manifestations of systemic symptom - fever
Timeframe: Through study completion, an average of 2 months.
The change of manifestations of systemic symptom - fatigue
Timeframe: Through study completion, an average of 2 months.
The change of manifestations of systemic symptoms - chest congestion
Timeframe: Through study completion, an average of 2 months.
The change of the emerging signs or symptoms of ischemia
Timeframe: Through study completion, an average of 2 months.
The change of the signs or symptoms of ischemia
Timeframe: Through study completion, an average of 2 months.
The change of the blood pressure
Timeframe: Through study completion, an average of 2 months.
The change of laboratory tests.
Timeframe: Through study completion, an average of 2 months.
The change of IL-6 in plasma
Timeframe: Through study completion, an average of 2 months.
The change of vascular imaging.
Timeframe: Through study completion, an average of 2 months.
The change of quality of life(QOF): SF-36 questionnaire
Timeframe: Through study completion, an average of 2 months.